Type 5 Diabetes: Malnutrition and GLP-1 Explained

Type 5 diabetes, or malnutrition-related diabetes mellitus, is a metabolic condition resulting from severe undernutrition during early development. Unlike autoimmune Type 1 or lifestyle-linked Type 2, it is characterized by underdeveloped pancreatic tissue and impaired insulin production. It primarily affects adolescents and young adults in resource-poor settings who have a history of protein-energy malnutrition.

The 2025 Shift: Defining Type 5 Diabetes

For decades, clinicians in the global south observed a form of diabetes that simply did not fit the traditional Type 1 or Type 2 boxes. Known historically as malnutrition-related diabetes mellitus (MRDM), this condition was often overlooked in Western medical literature. However, the landscape of endocrinology shifted significantly at the start of 2025. During the World Diabetes Congress, the medical community officially transitioned the terminology to Type 5 diabetes to ensure clinical accuracy and better resource allocation.

This update was not merely semantic. By recognizing Type 5 diabetes as a unique entity, health organizations can now better address the specific needs of the 20 to 25 million people worldwide who live with this condition. The prevalence is highest in South-East Asia and sub-Saharan Africa, where historical and ongoing food insecurity creates the specific physiological conditions necessary for the disease to manifest.

The necessity of this new classification stems from the fact that Type 5 is not driven by the modern sedentary lifestyle or the autoimmune destruction of beta cells. Instead, it is a metabolic scar left by early-life deprivation. In many low- and middle-income countries, the prevalence of this condition among young, lean males is a stark reminder of the long-term metabolic effects of chronic malnutrition.

2025 IDF Update: The International Diabetes Federation now recognizes Type 5 diabetes as a distinct clinical diagnosis, separating it from the generic "other" category to prioritize research into its unique insulin-resistant yet ketosis-resistant nature.

Diagnostic Criteria: How Type 5 Differs from Type 1 and 2

Identifying Type 5 diabetes requires a departure from standard diagnostic protocols used in North America or Europe. In those regions, a high blood sugar reading in a young person almost always points to Type 1, while in an older adult, it suggests Type 2. Type 5 diabetes challenges these assumptions. It typically emerges in adolescents or young adults who have a history of severe childhood deprivation.

The hallmark of the condition is a body mass index, typically less than 19 kg/m², often accompanied by clinical signs of past protein-energy malnutrition, such as skin changes or brittle hair. However, the most fascinating clinical marker is the lack of ketosis. In Type 1 diabetes, a lack of insulin leads to the breakdown of fats and the production of ketones, which can be fatal. Type 5 patients often have very high glucose levels—sometimes exceeding 400 mg/dL—yet they do not develop ketoacidosis.

Understanding these diagnostic criteria for malnutrition-related diabetes mellitus is essential for proper care. For instance, testing C-peptide levels is a crucial step. While Type 1 patients have almost no C-peptide (a marker of insulin production), Type 5 patients often show levels above 0.5 ng/mL, indicating that while their pancreas is impaired, it is not completely inactive. This indicates beta-cell dysfunction caused by pancreatic hypoplasia—essentially an undersized pancreas that cannot meet the body’s metabolic demands—rather than a total loss of cells.

The GLP-1 Link: Malnutrition and the Gut-Pancreas Axis

One of the most compelling areas of current research involves the gut-pancreas axis and its relationship to glucagon-like peptide-1 (GLP-1). This hormone is responsible for the incretin effect, which stimulates insulin secretion after eating. In healthy individuals, the gut signals the pancreas to prepare for a glucose load. In patients with Type 5 diabetes, this communication system appears to be broken.

Research suggests that chronic undernutrition affects GLP-1 secretion and the overall incretin effect. When the gut is deprived of nutrients during critical growth windows, the cells responsible for producing GLP-1 may not develop properly. This creates a secondary layer of metabolic failure; not only is the pancreas too small to produce enough insulin, but the gut also fails to send the necessary hormonal triggers to release what little insulin is available.

Interestingly, this connection has gained renewed attention due to the rise of GLP-1 receptor agonist medications used for weight loss. A clinical study revealed that 22.4% of adults newly prescribed GLP-1 receptor agonists were diagnosed with a nutritional deficiency within a year of starting therapy. This highlight's a modern "malnutrition" scenario where rapid weight loss can lead to significant lean mass loss—sometimes between 20% and 50%.

While these medication users do not have Type 5 diabetes, the metabolic parallel is striking. How childhood malnutrition affects GLP-1 secretion in Type 5 patients provides a roadmap for understanding how any form of severe nutrient deprivation can disrupt the delicate balance of the gut-pancreas axis. In Type 5 cases, the lack of GLP-1 activity further compounds the beta-cell dysfunction, making glucose management incredibly difficult without external intervention.

Management and Nutritional Rehabilitation

Treating Type 5 diabetes is far more complex than simply prescribing insulin. While insulin is necessary to manage hyperglycemia, it does not address the underlying pathology of malnutrition. In fact, if insulin is administered without proper nutritional support, it can exacerbate the patient's underlying weakness and muscle wasting.

The gold standard for nutritional management for type 5 diabetes recovery involves a dual approach: aggressive nutritional rehabilitation and tailored insulin regimens. Clinical care must focus on:

1. Protein-Energy Restoration: Patients need high-quality protein and adequate calories to rebuild lean mass. Without this, the metabolic effects of chronic malnutrition remain unaddressed, and the body cannot utilize insulin effectively.
2. Micronutrient Supplementation: Deficiencies in zinc, magnesium, and vitamin A are common in these populations and play a direct role in pancreatic health.
3. Resistance Exercise: For those who are physically able, light resistance training is recommended to combat the 20-50% lean mass loss often seen in chronically undernourished individuals. This helps improve insulin sensitivity in the remaining muscle tissue.
4. Glucose Monitoring: Because these patients are ketosis-resistant but still prone to severe high blood sugar, regular monitoring is vital to prevent long-term complications like nerve damage or kidney failure.

Looking toward 2026, experts are calling for "living documents" in clinical guidelines that prioritize these holistic interventions. We are moving away from the idea that diabetes is just about "lowering the number." Especially in Type 5 diabetes, the goal is to restore the biological foundation that was denied during childhood.

FAQ

What is type 5 diabetes?

Type 5 diabetes is a form of diabetes caused by severe malnutrition during early childhood. It results in an underdeveloped pancreas that cannot produce enough insulin, leading to high blood sugar in people who are typically very lean.

What are the symptoms of type 5 diabetes?

Symptoms often mirror other forms of diabetes, including frequent urination (polyuria) and extreme thirst (polydipsia). However, unique indicators include a body mass index under 19 kg/m², a history of childhood undernutrition, and a lack of ketoacidosis even when blood sugar is high.

How is type 5 diabetes different from type 2?

While Type 2 is characterized by insulin resistance and is often linked to being overweight, Type 5 is caused by an physical inability to produce enough insulin due to an underdeveloped pancreas. Type 5 patients are almost always underweight or very lean.

What causes type 5 diabetes to develop?

The primary cause is chronic protein-energy malnutrition during the first few years of life. This deprivation prevents the pancreas and the gut-pancreas axis from developing fully, leading to lifelong metabolic issues.

Is type 5 diabetes the same as MARD?

Yes, MARD stands for malnutrition-related diabetes mellitus. This was the clinical name for the condition for many years before it was officially updated to Type 5 diabetes by international health organizations in 2025.

Is type 5 diabetes a recognized medical classification?

Yes, as of January 2025, the International Diabetes Federation (IDF) officially recognized it as a distinct classification of the disease to improve diagnosis and treatment in affected global regions.